Literature DB >> 10652487

Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development.

M Aidoo1, V Udhayakumar.   

Abstract

The search for a cytotoxic T lymphocyte (CTL)-inducing malaria vaccine has moved forward from epitope identification to planning stages of safety and immunogenicity trials of candidate vaccines. Development of CTL-inducing vaccine candidates has taken center stage based on the observation that CTL-mediated protection might be the dominant mechanism by which sterile immunity is achieved in irradiated sporozoite immunization experiments in humans and laboratory animals. However, studies in naturally infected individuals living in endemic areas, as reviewed here by Michael Aidoo and Venkatachalam Udhayakumar, have revealed that CTL induction might be influenced by factors such as parasite variants, host genes, other infections and transmission patterns. The influence of these factors on CTL induction has been demonstrated individually and in various combinations in controlled animal experiments. However, in naturally infected humans, they are presented in a complex host-parasite-environment interaction, in a manner that is not easily achieved in laboratory-based experiments. Understanding these interactions is crucial for the development and testing of CTL-inducing vaccines for humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652487     DOI: 10.1016/s0169-4758(99)01592-6

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  10 in total

1.  Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects.

Authors:  C Nilsson; S Aboud; K Karlén; B Hejdeman; W Urassa; G Biberfeld
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

2.  Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells.

Authors:  Benjamin J Burwitz; Chad J Pendley; Justin M Greene; Ann M Detmer; Jennifer J Lhost; Julie A Karl; Shari M Piaskowski; Richard A Rudersdorf; Lyle T Wallace; Benjamin N Bimber; John T Loffredo; Daryl G Cox; Wilfried Bardet; William Hildebrand; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

3.  What can we learn from an unnatural immune response?

Authors:  Brandy Lee Bennett; Photini Sinnis
Journal:  Trends Parasitol       Date:  2010-04-27

4.  Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.

Authors:  Asma Abdullah Nurul; Mohd Nor Norazmi
Journal:  Parasitol Res       Date:  2010-11-06       Impact factor: 2.289

Review 5.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Authors:  S L Takala; C V Plowe
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

6.  Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii.

Authors:  K A Wong; A Zhou; A Rodriguez
Journal:  Parasite Immunol       Date:  2008-09       Impact factor: 2.280

7.  Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.

Authors:  Magaly Chinchilla; Marcela F Pasetti; Sandra Medina-Moreno; Jin Yuan Wang; Oscar G Gomez-Duarte; Rick Stout; Myron M Levine; James E Galen
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

8.  Emerging microfluidic tools for functional cellular immunophenotyping: a new potential paradigm for immune status characterization.

Authors:  Weiqiang Chen; Nien-Tsu Huang; Xiang Li; Zeta Tak For Yu; Katsuo Kurabayashi; Jianping Fu
Journal:  Front Oncol       Date:  2013-04-22       Impact factor: 6.244

9.  Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage.

Authors:  Tzvi Pollock; Ricardo Leitao; Cristina Galan-Rodriguez; Kurt A Wong; Ana Rodriguez
Journal:  Malar J       Date:  2011-04-18       Impact factor: 2.979

10.  Malaria blood stage suppression of liver stage immunity by dendritic cells.

Authors:  Carlos Ocaña-Morgner; Maria M Mota; Ana Rodriguez
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.